{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:56:06Z","timestamp":1791186966920,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021692","name":"LabEx PRIMES","doi-asserted-by":"publisher","award":["ANR-11-LABX-0063"],"award-info":[{"award-number":["ANR-11-LABX-0063"]}],"id":[{"id":"10.13039\/501100021692","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GRAL","award":["ANR-17-EURE-0003"],"award-info":[{"award-number":["ANR-17-EURE-0003"]}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["2022-2023, \u00ab Traitement par inhibiteurs de KRAS en association avec l\u2019irradiation X vs ions carbone dans le cancer bronchique non \u00e0 petite cellule (CBNPC) avec mutation KRAS \u00bb"],"award-info":[{"award-number":["2022-2023, \u00ab Traitement par inhibiteurs de KRAS en association avec l\u2019irradiation X vs ions carbone dans le cancer bronchique non \u00e0 petite cellule (CBNPC) avec mutation KRAS \u00bb"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016036","name":"\u00c9lectricit\u00e9 de France","doi-asserted-by":"publisher","award":["committee \u00ab Protection de l\u2019Homme et de l\u2019Environnement (CPPHE) \u00bb, under the Life Sciences group of the four-way national agreement CEA-EDF-IRSN-Framatome, \u201cR\u00f4le de KRAS dans la modulation de la radior\u00e9sistance et du statut inflammatoire dans le cancer bronchique non \u00e0 petites cellules"],"award-info":[{"award-number":["committee \u00ab Protection de l\u2019Homme et de l\u2019Environnement (CPPHE) \u00bb, under the Life Sciences group of the four-way national agreement CEA-EDF-IRSN-Framatome, \u201cR\u00f4le de KRAS dans la modulation de la radior\u00e9sistance et du statut inflammatoire dans le cancer bronchique non \u00e0 petites cellules"]}],"id":[{"id":"10.13039\/501100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05668-x","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:36:14Z","timestamp":1785490574000},"page":"4441-4452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radio-sensitization of mutated KRAS G12C non-small cell lung cancer with KRAS G12C tyrosine kinase inhibitor and carbon ions irradiation"],"prefix":"10.1007","volume":"481","author":[{"given":"Mathieu","family":"C\u00e9saire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Lecrosnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Sitarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahra","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Chartier-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Testard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu\u00e9na\u00eblle","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Christy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Cand\u00e9ias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8488-2324","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"5668_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W, Choy H (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 16:187\u2013199. https:\/\/doi.org\/10.1016\/S1470-2045(14)71207-0","journal-title":"Lancet Oncol"},{"key":"5668_CR2","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","volume":"379","author":"SJ Antonia","year":"2018","unstructured":"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpe\u00f1o J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, \u00d6zg\u00fcro\u011flu M, PACIFIC Investigators (2018) Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. N Engl J Med 379:2342\u20132350. https:\/\/doi.org\/10.1056\/NEJMoa1809697","journal-title":"N Engl J Med"},{"key":"5668_CR3","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/cas.12740","volume":"106","author":"S Yagishita","year":"2015","unstructured":"Yagishita S, Horinouchi H, Sunami KS, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Shiraishi K, Kohno T, Furuta K, Tsuta K, Tamura T, Ohe Y (2015) Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer. Cancer Sci 106:1402\u20131407. https:\/\/doi.org\/10.1111\/cas.12740","journal-title":"Cancer Sci"},{"key":"5668_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jtho.2021.02.016","volume":"16","author":"SP Finn","year":"2021","unstructured":"Finn SP, Addeo A, Dafni U, Thunnissen E, Bubendorf L, Madsen LB, Biernat W, Verbeken E, Hernandez-Losa J, Marchetti A, Cheney R, Warth A, Speel E-JM, Quinn AM, Monkhorst K, Jantus-Lewintre E, Tischler V, Marti N, Dimopoulou G, Molina-Vila MA, Kammler R, Kerr KM, Peters S, Stahel RA, European Thoracic Oncology Platform Lungscape Investigators (2021) Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 16:990\u20131002. https:\/\/doi.org\/10.1016\/j.jtho.2021.02.016","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"5668_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","volume":"383","author":"DS Hong","year":"2020","unstructured":"Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, Falchook GS, Price TJ, Sacher A, Denlinger CS, Bang Y-J, Dy GK, Krauss JC, Kuboki Y, Kuo JC, Coveler AL, Park K, Kim TW, Barlesi F, Munster PN, Ramalingam SS, Burns TF, Meric-Bernstam F, Henary H, Ngang J, Ngarmchamnanrith G, Kim J, Houk BE, Canon J, Lipford JR, Friberg G, Lito P, Govindan R, Li BT (2020) KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors. N Engl J Med 383:1207\u20131217. https:\/\/doi.org\/10.1056\/NEJMoa1917239","journal-title":"N Engl J Med"},{"key":"5668_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jtho.2021.04.015","volume":"16","author":"T Koga","year":"2021","unstructured":"Koga T, Suda K, Fujino T, Ohara S, Hamada A, Nishino M, Chiba M, Shimoji M, Takemoto T, Arita T, Gmachl M, Hofmann MH, Soh J, Mitsudomi T (2021) KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 16:1321\u20131332. https:\/\/doi.org\/10.1016\/j.jtho.2021.04.015","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"5668_CR7","doi-asserted-by":"publisher","unstructured":"(2022) Adagrasib Response Remains Strong in NSCLC. Cancer Discov 12:OF1. https:\/\/doi.org\/10.1158\/2159-8290.CD-NB2022-0042","DOI":"10.1158\/2159-8290.CD-NB2022-0042"},{"key":"5668_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","volume":"575","author":"J Canon","year":"2019","unstructured":"Canon J, Rex K, Saiki AY, Mohr C, Cooke K, Bagal D, Gaida K, Holt T, Knutson CG, Koppada N, Lanman BA, Werner J, Rapaport AS, San Miguel T, Ortiz R, Osgood T, Sun J-R, Zhu X, McCarter JD, Volak LP, Houk BE, Fakih MG, O\u2019Neil BH, Price TJ, Falchook GS, Desai J, Kuo J, Govindan R, Hong DS, Ouyang W, Henary H, Arvedson T, Cee VJ, Lipford JR (2019) The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575:217\u2013223. https:\/\/doi.org\/10.1038\/s41586-019-1694-1","journal-title":"Nature"},{"key":"5668_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1158\/1541-7786.MCR-09-0507","volume":"8","author":"EJ Choi","year":"2010","unstructured":"Choi EJ, Ryu YK, Kim SY, Wu HG, Kim JS, Kim IH, Kim IA (2010) Targeting epidermal growth factor receptor-associated signaling pathways in non-small cell lung cancer cells: implication in radiation response. Mol Cancer Res MCR 8:1027\u20131036. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0507","journal-title":"Mol Cancer Res MCR"},{"key":"5668_CR10","doi-asserted-by":"publisher","first-page":"116058","DOI":"10.1016\/j.biopha.2023.116058","volume":"171","author":"M Xu","year":"2024","unstructured":"Xu M, Zhao X, Wen T, Qu X (2024) Unveiling the role of KRAS in tumor immune microenvironment. Biomed Pharmacother Biomedecine Pharmacother 171:116058. https:\/\/doi.org\/10.1016\/j.biopha.2023.116058","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"22","key":"5668_CR11","doi-asserted-by":"publisher","first-page":"00178","DOI":"10.1016\/j.trsl.2022.08.005","volume":"S1931\u20135244","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Liu Y, Zhang F, Su C, Chen X, Zhang M, Sun M, Sun Y, Xing L (2022) Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models. Transl Res J Lab Clin Med S1931\u20135244(22):00178\u201300175. https:\/\/doi.org\/10.1016\/j.trsl.2022.08.005","journal-title":"Transl Res J Lab Clin Med"},{"key":"5668_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12967-023-04619-0","volume":"21","author":"P-A Laurent","year":"2023","unstructured":"Laurent P-A, Milic M, Quevrin C, Meziani L, Liu W, Morel D, Signolle N, Cl\u00e9menson C, Levy A, Mondini M, Deutsch E (2023) KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner. J Transl Med 21:773. https:\/\/doi.org\/10.1186\/s12967-023-04619-0","journal-title":"J Transl Med"},{"key":"5668_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcb.30506","volume":"125","author":"L Soundararajan","year":"2024","unstructured":"Soundararajan L, Warrier S, Dharmarajan A, Bhaskaran N (2024) Predominant factors influencing reactive oxygen species in cancer stem cells. J Cell Biochem 125:3\u201321. https:\/\/doi.org\/10.1002\/jcb.30506","journal-title":"J Cell Biochem"},{"key":"5668_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1476-4598-12-94","volume":"12","author":"R Gomez-Casal","year":"2013","unstructured":"Gomez-Casal R, Bhattacharya C, Ganesh N, Bailey L, Basse P, Gibson M, Epperly M, Levina V (2013) Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Mol Cancer 12:94. https:\/\/doi.org\/10.1186\/1476-4598-12-94","journal-title":"Mol Cancer"},{"key":"5668_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.22074\/cellj.2022.8403","volume":"24","author":"M Raei","year":"2022","unstructured":"Raei M, Bagheri M, Aghaabdollahian S, Ghorbani M, Sadeghi A (2022) Ionizing Radiation Promotes Epithelial-Mesenchymal Transition Phenotype and Stem Cell Marker in The Lung adenocarcinoma: In Vitro and Bioinformatic Studiesc. Cell J 24:522\u2013530. https:\/\/doi.org\/10.22074\/cellj.2022.8403","journal-title":"Cell J"},{"key":"5668_CR16","doi-asserted-by":"publisher","first-page":"116562","DOI":"10.1016\/j.lfs.2019.116562","volume":"232","author":"A Tsolou","year":"2019","unstructured":"Tsolou A, Lamprou I, Fortosi A-O, Liousia M, Giatromanolaki A, Koukourakis MI (2019) Stemness and senescence related escape pathways are dose dependent in lung cancer cells surviving post irradiation. Life Sci 232:116562. https:\/\/doi.org\/10.1016\/j.lfs.2019.116562","journal-title":"Life Sci"},{"key":"5668_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cancers8010008","volume":"8","author":"MR Doherty","year":"2016","unstructured":"Doherty MR, Smigiel JM, Junk DJ, Jackson MW (2016) Cancer Stem Cell Plasticity Drives Therapeutic Resistance. Cancers 8:8. https:\/\/doi.org\/10.3390\/cancers8010008","journal-title":"Cancers"},{"key":"5668_CR18","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00018-018-2794-z","volume":"75","author":"A Bernal","year":"2018","unstructured":"Bernal A, Arranz L (2018) Nestin-expressing progenitor cells: function, identity and therapeutic implications. Cell Mol Life Sci CMLS 75:2177\u20132195. https:\/\/doi.org\/10.1007\/s00018-018-2794-z","journal-title":"Cell Mol Life Sci CMLS"},{"key":"5668_CR19","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci CMLS 68:3033\u20133046. https:\/\/doi.org\/10.1007\/s00018-011-0735-1","journal-title":"Cell Mol Life Sci CMLS"},{"key":"5668_CR20","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.18632\/oncotarget.3584","volume":"6","author":"S Sai","year":"2015","unstructured":"Sai S, Wakai T, Vares G, Yamada S, Kamijo T, Kamada T, Shirai T (2015) Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo. Oncotarget 6:5517\u20135535. https:\/\/doi.org\/10.18632\/oncotarget.3584","journal-title":"Oncotarget"},{"key":"5668_CR21","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1158\/0008-5472.CAN-10-2926","volume":"71","author":"X Cui","year":"2011","unstructured":"Cui X, Oonishi K, Tsujii H, Yasuda T, Matsumoto Y, Furusawa Y, Akashi M, Kamada T, Okayasu R (2011) Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res 71:3676\u20133687. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2926","journal-title":"Cancer Res"},{"key":"5668_CR22","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1096\/fj.13-242230","volume":"28","author":"FSB Subtil","year":"2014","unstructured":"Subtil FSB, Wilhelm J, Bill V, Westholt N, Rudolph S, Fischer J, Scheel S, Seay U, Fournier C, Taucher-Scholz G, Scholz M, Seeger W, Engenhart-Cabillic R, Rose F, Dahm-Daphi J, H\u00e4nze J (2014) Carbon ion radiotherapy of human lung cancer attenuates HIF-1 signaling and acts with considerably enhanced therapeutic efficiency. FASEB J Off Publ Fed Am Soc Exp Biol 28:1412\u20131421. https:\/\/doi.org\/10.1096\/fj.13-242230","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"5668_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13014-017-0939-0","volume":"12","author":"C Klein","year":"2017","unstructured":"Klein C, Dokic I, Mairani A, Mein S, Brons S, H\u00e4ring P, Haberer T, J\u00e4kel O, Zimmermann A, Zenke F, Blaukat A, Debus J, Abdollahi A (2017) Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation. Radiat Oncol Lond Engl 12:208. https:\/\/doi.org\/10.1186\/s13014-017-0939-0","journal-title":"Radiat Oncol Lond Engl"},{"key":"5668_CR24","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.3390\/cancers13143421","volume":"13","author":"J Ancel","year":"2021","unstructured":"Ancel J, Perotin J-M, Dewolf M, Launois C, Mulette P, Nawrocki-Raby B, Dalstein V, Gilles C, Desl\u00e9e G, Polette M, Dormoy V (2021) Hypoxia in Lung Cancer Management: A Translational Approach. Cancers 13:3421. https:\/\/doi.org\/10.3390\/cancers13143421","journal-title":"Cancers"},{"key":"5668_CR25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/cas.13890","volume":"110","author":"K Hayashi","year":"2019","unstructured":"Hayashi K, Yamamoto N, Nakajima M, Nomoto A, Tsuji H, Ogawa K, Kamada T (2019) Clinical outcomes of carbon-ion radiotherapy for locally advanced non-small-cell lung cancer. Cancer Sci 110:734\u2013741. https:\/\/doi.org\/10.1111\/cas.13890","journal-title":"Cancer Sci"},{"key":"5668_CR26","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/cncr.29195","volume":"121","author":"W Takahashi","year":"2015","unstructured":"Takahashi W, Nakajima M, Yamamoto N, Yamashita H, Nakagawa K, Miyamoto T, Tsuji H, Kamada T, Fujisawa T (2015) A prospective nonrandomized phase I\/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC). Cancer 121:1321\u20131327. https:\/\/doi.org\/10.1002\/cncr.29195","journal-title":"Cancer"},{"key":"5668_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nima.2016.01.052","volume":"816","author":"F Durantel","year":"2016","unstructured":"Durantel F, Balanzat E, Cassimi A, Chevalier F, Ngono-Ravache Y, Madi T, Poully J-C, Ramillon J-M, Rothard H, Ropars F, Schwob L, Testard I, Saintigny Y (2016) Dosimetry for radiobiology experiments at GANIL. Nucl Instrum Methods Phys Res Sect Accel Spectrometers Detect Assoc Equip 816:70\u201377. https:\/\/doi.org\/10.1016\/j.nima.2016.01.052","journal-title":"Nucl Instrum Methods Phys Res Sect Accel Spectrometers Detect Assoc Equip"},{"key":"5668_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/biom14091071","volume":"14","author":"A Gilbert","year":"2024","unstructured":"Gilbert A, Tudor M, Delaunay A, Leman R, Levilly J, Atkinson A, Cast\u00e9ra L, Dinischiotu A, Savu DI, Valable S, Chevalier F (2024) Radiosensitizing Effect of PARP Inhibition on Chondrosarcoma and Chondrocyte Cells Is Dependent on Radiation LET. Biomolecules 14:1071. https:\/\/doi.org\/10.3390\/biom14091071","journal-title":"Biomolecules"},{"key":"5668_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0273-1177(95)00784-c","volume":"18","author":"M Scholz","year":"1996","unstructured":"Scholz M, Kraft G (1996) Track structure and the calculation of biological effects of heavy charged particles. Adv Space Res Off J Comm Space Res 18:5\u201314. https:\/\/doi.org\/10.1016\/0273-1177(95)00784-c","journal-title":"Adv Space Res Off J Comm Space Res"},{"key":"5668_CR30","doi-asserted-by":"publisher","first-page":"100246","DOI":"10.1016\/j.jbo.2019.100246","volume":"17","author":"M C\u00e9saire","year":"2019","unstructured":"C\u00e9saire M, Ghosh U, Austry J-B, Muller E, Cammarata FP, Guillamin M, Caruso M, Cast\u00e9ra L, Petringa G, Cirrone GAP, Chevalier F (2019) Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation. J Bone Oncol 17:100246. https:\/\/doi.org\/10.1016\/j.jbo.2019.100246","journal-title":"J Bone Oncol"},{"key":"5668_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/jrr\/rrac094","volume":"64","author":"I Testard","year":"2023","unstructured":"Testard I, Garcia-Chartier E, Issa A, Collin-Faure V, Aude-Garcia C, Cand\u00e9ias SM (2023) Bystander signals from low- and high-dose irradiated human primary fibroblasts and keratinocytes modulate the inflammatory response of peripheral blood mononuclear cells. J Radiat Res (Tokyo) 64:304\u2013316. https:\/\/doi.org\/10.1093\/jrr\/rrac094","journal-title":"J Radiat Res (Tokyo)"},{"key":"5668_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.31083\/j.fbl2709277","volume":"27","author":"A Gilbert","year":"2022","unstructured":"Gilbert A, Payet V, Bernay B, Chartier-Garcia E, Testard I, Cand\u00e9ias SM, Chevalier F (2022) Label-Free Direct Mass Spectrometry Analysis of the Bystander Effects Induced in Chondrocytes by Chondrosarcoma Cells Irradiated with X-rays and Carbon Ions. Front Biosci-Landmark 27:277. https:\/\/doi.org\/10.31083\/j.fbl2709277","journal-title":"Front Biosci-Landmark"},{"key":"5668_CR33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41419-019-1898-1","volume":"10","author":"A Herreros-Pomares","year":"2019","unstructured":"Herreros-Pomares A, de-Maya-Girones JD, Calabuig-Fari\u00f1as S, Lucas R, Mart\u00ednez A, Pardo-S\u00e1nchez JM, Alonso S, Blasco A, Guijarro R, Martorell M, Escorihuela E, Chiara MD, Dur\u00e9ndez E, Gand\u00eda C, Forteza J, Sirera R, Jantus-Lewintre E, Farr\u00e0s R, Camps C (2019) Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer. Cell Death Dis 10:660. https:\/\/doi.org\/10.1038\/s41419-019-1898-1","journal-title":"Cell Death Dis"},{"key":"5668_CR34","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1038\/s41467-019-12925-9","volume":"10","author":"J Wang","year":"2019","unstructured":"Wang J, Lu Q, Cai J, Wang Y, Lai X, Qiu Y, Huang Y, Ke Q, Zhang Y, Guan Y, Wu H, Wang Y, Liu X, Shi Y, Zhang K, Wang M, Peng Xiang A (2019) Nestin regulates cellular redox homeostasis in lung cancer through the Keap1-Nrf2 feedback loop. Nat Commun 10:5043. https:\/\/doi.org\/10.1038\/s41467-019-12925-9","journal-title":"Nat Commun"},{"key":"5668_CR35","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/bjophthalmol-2018-313285","volume":"104","author":"M Bhardwaj","year":"2020","unstructured":"Bhardwaj M, Sen S, Chosdol K, Bakhshi S, Pushker N, Sharma A, Kashyap S, Bajaj MS, Singh VK (2020) Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma. Br J Ophthalmol 104:879\u2013884. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313285","journal-title":"Br J Ophthalmol"},{"key":"5668_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/JTO.0000000000000021","volume":"9","author":"W Sterlacci","year":"2014","unstructured":"Sterlacci W, Savic S, Fiegl M, Obermann E, Tzankov A (2014) Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 9:41\u201349. https:\/\/doi.org\/10.1097\/JTO.0000000000000021","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"5668_CR37","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1111\/cas.15972","volume":"114","author":"DJ Buglewicz","year":"2023","unstructured":"Buglewicz DJ, Buglewicz JKF, Hirakawa H, Kato TA, Liu C, Fang Y, Kusumoto T, Fujimori A, Sai S (2023) The impact of DNA double-strand break repair pathways throughout the carbon ion spread-out Bragg peak beam. Cancer Sci 114:4548\u20134557. https:\/\/doi.org\/10.1111\/cas.15972","journal-title":"Cancer Sci"},{"key":"5668_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41698-025-00800-4","volume":"9","author":"BJ Sishc","year":"2025","unstructured":"Sishc BJ, Saha J, Alves EM, Ding L, Lu H, Wang S-Y, Swancutt KL, Nicholson JH, Facoetti A, Pompos A, Ciocca M, Aguilera TA, Story MD, Davis AJ (2025) Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer. NPJ Precis Oncol 9:20. https:\/\/doi.org\/10.1038\/s41698-025-00800-4","journal-title":"NPJ Precis Oncol"},{"key":"5668_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5483\/BMBRep.2019.52.2.213","volume":"52","author":"J Hu","year":"2019","unstructured":"Hu J, Zhang Z, Zhao L, Li L, Zuo W, Han L (2019) High expression of RAD51 promotes DNA damage repair and survival in KRAS-mutant lung cancer cells. BMB Rep 52:151\u2013156. https:\/\/doi.org\/10.5483\/BMBRep.2019.52.2.213","journal-title":"BMB Rep"},{"key":"5668_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cam4.20","volume":"2","author":"CM Gutschalk","year":"2013","unstructured":"Gutschalk CM, Yanamandra AK, Linde N, Meides A, Depner S, Mueller MM (2013) GM-CSF enhances tumor invasion by elevated MMP-2, -9, and \u2013\u200926 expression. Cancer Med 2:117\u2013129. https:\/\/doi.org\/10.1002\/cam4.20","journal-title":"Cancer Med"},{"key":"5668_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","volume":"40","author":"E Limagne","year":"2022","unstructured":"Limagne E, Nuttin L, Thibaudin M, Jacquin E, Aucagne R, Bon M, Revy S, Barnestein R, Ballot E, Truntzer C, Derang\u00e8re V, Fumet J-D, Latour C, R\u00e9b\u00e9 C, Bellaye P-S, Kaderbha\u00ef C-G, Spill A, Collin B, Callanan MB, Lagrange A, Favier L, Coudert B, Arnould L, Ladoire S, Routy B, Joubert P, Ghiringhelli F (2022) MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells. Cancer Cell 40:136\u2013152e12. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.009","journal-title":"Cancer Cell"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05668-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:09Z","timestamp":1791186309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05668-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5668"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05668-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9469593\/v1","asserted-by":"object"}]},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}